

U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.
You can purchase shares of C3.ai (NYSE:AI) through any online brokerage.
Other companies in C3.ai’s space includes: Palantir Technologies Inc (NASDAQ:PLTR), SAP SE (NYSE:SAP), Salesforce Inc (NYSE:CRM), Adobe Inc (NASDAQ:ADBE) and Intuit Inc (NASDAQ:INTU).
C3.ai has a consensus price target of $18.74.
The stock price for C3.ai (NYSE: AI) is $11.4868 last updated November 3, 2026 at 7:50 PM EST.
There are no upcoming dividends for C3.ai.
C3.ai does not have any upcoming earnings scheduled.
There is no upcoming split for C3.ai.
C3.ai is in the Information Technology sector and Software industry. They are listed on the NYSE.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It...